Brainify.AI is an artificial intelligence/machine learning biomarker platform for the development of novel treatments for depression that increases the likelihood of new treatment approval by 80% and reduces R&D costs.
Location: United States, New York
Employees: 11-50
Total raised: $1M
Founded date: 2021
Investors 1
| Date | Name | Website |
| - | Merck Digi... | mds.studio |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 09.01.2023 | Pre-Seed | $1M | - |
Mentions in press and media 4
| Date | Title | Description |
| 18.04.2024 | Brainify.AI Welcomes Dr. Jim Doherty as New Advisory Board Member | Dr. Jim Doherty, seasoned CNS R&D leader, joins Brainify.AI's advisory board, bringing over two decades of pharmaceutical expertise and innovative leadership. Dr. Doherty's unparalleled expertise in CNS research will be invaluable as we... |
| 16.01.2024 | Brainify.AI's CEO Miriam Speaks on AI's Impact in Psychiatry at the World Economic Forum | World Economic Forum Brainify.AI CEO Mariam Khayretdinova discusses AI in psychiatry at World Economic Forum, highlighting innovation in depression treatment AI is revolutionizing psychiatric care, enhancing treatment precision and patient ... |
| 09.01.2024 | Brainify.AI Showcases AI-Driven Psychiatry Platform at Biotech Showcase™ 2024: Pioneering Antidepressant Development | Brainify.AI Brainify.AI Announces Successful Investment Round Led by Industry Leaders VC and acceptance into Merck Digital Sciences Studio Brainify.AI unveils R&D and company growth at Biotech Showcase 2024, highlighting investment mile... |
| 15.05.2023 | Ivan Mishanin, Brainify.AI: “Never abandon your vision” | Noah Miller, Tech Times 15 May 2023, 03:05 pm (Photo : Ivan Mishanin) Ivan Mishanin, an experienced technology entrepreneur, was a co-founder and CEO of Bright Box, a software vendor for globally connected cars, for more than eight years. D... |